Cargando…
Enhanced efficacy with azacytidine and oncolytic BHV-1 in a tolerized cotton rat model of breast adenocarcinoma
Oncolytic viruses selectively replicate in cancer cells by exploiting biochemical differences between normal and tumor cells. Treatment with epigenetic modifiers such as 5-Azacytidine, a DNA methyltransferase inhibitor, increases the replication and cytotoxicity of oncolytic viruses in vivo and in v...
Autores principales: | Cuddington, Breanne P, Verschoor, Meghan, Ashkar, Ali, Mossman, Karen L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782958/ https://www.ncbi.nlm.nih.gov/pubmed/27119103 http://dx.doi.org/10.1038/mto.2015.4 |
Ejemplares similares
-
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells
por: Davola, Maria Eugenia, et al.
Publicado: (2023) -
The Importance of Physiologically Relevant Cell Lines for Studying Virus–Host Interactions
por: Hare, David, et al.
Publicado: (2016) -
Epidemiology and genetic characterization of BVDV, BHV-1, BHV-4, BHV-5 and
Brucella spp. infections in cattle in Turkey
por: ASLAN, Muhammet Eren, et al.
Publicado: (2015) -
DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus
por: Kedarinath, Kritika, et al.
Publicado: (2023) -
Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
por: Davola, Maria Eugenia, et al.
Publicado: (2019)